Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Background prevalence of microagglutination antibodies to Legionella pneumophila serogroups 1, 2, 3, and 4.

Literature DB >> 7439997

Background prevalence of microagglutination antibodies to Legionella pneumophila serogroups 1, 2, 3, and 4.

C M Helms, W Johnson, E D Renner, W J Hierholzer, L A Wintermeyer, J P Viner.

Abstract

The background prevalence of microagglutination antibodies to Legionella pneumophila was determined by testing the sera of 517 individuals who lived or worked in a small Iowa town. In this population, the upper limit of normal microagglutination titer for serogroups 1, 3, and 4 was 1:16, and that for serogroup 2 was 1:8. The prevalence of microagglutination titers of greater than or equal to 1:32 against any serogroup of L. pneumophila was only 7.4% and did not vary significantly with age or sex.

Entities: Species

Mesh：

Substances：

Year: 1980 PMID： 7439997 PMCID： PMC551354 DOI： 10.1128/iai.30.2.612-614.1980

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

5 in total

1. Upper limit of normal titer for detection of antibodies to Legionella pneumophila by the microagglutination test.

Authors: G C Klein; W L Jones; J C Feeley
Journal: J Clin Microbiol Date: 1979-11 Impact factor: 5.948

2. Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine.

Authors: K H Wong; W O Schalla; R J Arko; J C Bullard; J C Feeley
Journal: Ann Intern Med Date: 1979-04 Impact factor: 25.391

3. The rickettsia-like organisms TATLOCK (1943) and HEBA (1959): bacteria phenotypically similar to but genetically distinct from Legionella pneumophila and the WIGA bacterium.

Authors: G A Hébert; C W Moss; L K McDougal; F M Bozeman; R M McKinney; D J Brenner
Journal: Ann Intern Med Date: 1980-01 Impact factor: 25.391

4. Detection of antibodies to legionnaires disease organism by microagglutination and micro-enzyme-linked immunosorbent assay tests.

Authors: C E Farshy; G C Klein; J C Feeley
Journal: J Clin Microbiol Date: 1978-04 Impact factor: 5.948

5. "Upper limits of normal" antistreptolysin O and antideoxyribonuclease B titers.

Authors: G C Klein; C N Baker; W L Jones
Journal: Appl Microbiol Date: 1971-06

5 in total

6 in total

Background prevalence of microagglutination antibodies to Legionella pneumophila serogroups 1, 2, 3, and 4.

1. Upper limit of normal titer for detection of antibodies to Legionella pneumophila by the microagglutination test.

2. Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine.

3. The rickettsia-like organisms TATLOCK (1943) and HEBA (1959): bacteria phenotypically similar to but genetically distinct from Legionella pneumophila and the WIGA bacterium.

4. Detection of antibodies to legionnaires disease organism by microagglutination and micro-enzyme-linked immunosorbent assay tests.

5. "Upper limits of normal" antistreptolysin O and antideoxyribonuclease B titers.

Review 1. Current and emerging Legionella diagnostics for laboratory and outbreak investigations.

Review 2. Diagnosis of Legionella infection in Legionnaires' disease.

3. Prevalence of Legionella pneumophila serogroup 1 antibodies in blood donors.

4. Relative potency of virulent versus avirulent Legionella pneumophila for induction of cell-mediated immunity.

5. An outbreak of community-acquired Legionnaires' disease pneumonia.

6. Prevalence of antibodies to Legionella pneumophila in animal populations.